These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 15455394)
1. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394 [TBL] [Abstract][Full Text] [Related]
2. alpha-Synuclein and Parkinson disease susceptibility. Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362 [TBL] [Abstract][Full Text] [Related]
3. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467 [TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease. Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306 [TBL] [Abstract][Full Text] [Related]
5. alpha-Synuclein locus triplication causes Parkinson's disease. Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171 [No Abstract] [Full Text] [Related]
6. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051 [TBL] [Abstract][Full Text] [Related]
7. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Mellick GD; Maraganore DM; Silburn PA Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652 [TBL] [Abstract][Full Text] [Related]
8. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997 [TBL] [Abstract][Full Text] [Related]
9. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111 [TBL] [Abstract][Full Text] [Related]
10. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335 [TBL] [Abstract][Full Text] [Related]
11. Gene dosage and pathogenesis of Parkinson's disease. Eriksen JL; Przedborski S; Petrucelli L Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766 [TBL] [Abstract][Full Text] [Related]
12. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease. Gispert S; Trenkwalder C; Mota-Vieira L; Kostic V; Auburger G Arch Neurol; 2005 Jan; 62(1):96-8. PubMed ID: 15642855 [TBL] [Abstract][Full Text] [Related]
13. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease. Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958 [TBL] [Abstract][Full Text] [Related]
15. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559 [TBL] [Abstract][Full Text] [Related]
16. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population. Yu L; Xu P; He X; Hu F; Lin Z; Zhu M; Liu Z; He L; Xu Y Brain Res; 2010 Jul; 1346():262-5. PubMed ID: 20513365 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein mRNA expression in sporadic Parkinson's disease. Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423 [TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population. Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971 [TBL] [Abstract][Full Text] [Related]
19. Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning. Kéri S; Nagy H; Myers CE; Benedek G; Shohamy D; Gluck MA Genes Brain Behav; 2008 Feb; 7(1):31-6. PubMed ID: 17451452 [TBL] [Abstract][Full Text] [Related]
20. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients]. Chen X; Liu YT; Li JR; Chen L; Xu YM; Pan YH; Meng XH; Xing SH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):536-8. PubMed ID: 14669226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]